Gene · 429
Papers4,495
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,301 to 1,320 of 4,495
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Empowering consumers to PREVENT diet-related diseases through OMICS sciences (PREVENTOMICS): protocol for a parallel double-blinded randomised intervention trial to investigate biomarker-based nutrition plans for weight loss. | BMJ Open | 2022 | 35351696 | PubTator, text mining | PubMed |
| LMO3 promotes proliferation and metastasis of papillary thyroid carcinoma cells by regulating LIMK1-mediated cofilin and the β-catenin pathway. | Open Med (Wars) | 2022 | 35350839 | PubTator, text mining | PubMed |
| Molecular Subtypes of High-Grade Neuroendocrine Carcinoma (HGNEC): What is YAP1-Positive HGNEC? | Front Biosci (Landmark Ed) | 2022 | 35345340 | PubTator, text mining | PubMed |
| The Role of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in Diabetes-Related Neurodegenerative Diseases. | Drug Des Devel Ther | 2022 | 35340338 | PubTator, text mining | PubMed |
| Choosing Kinase Inhibitors for Androgen Deprivation Therapy-Resistant Prostate Cancer. | Pharmaceutics | 2022 | 35335873 | PubTator, text mining | PubMed |
| Notch signaling pathway: architecture, disease, and therapeutics. | Signal Transduct Target Ther | 2022 | 35332121 | PubTator, text mining | PubMed |
| Editorial: Challenges and Opportunities for Neuromuscular Disease Modelling Using Urine-derived Stem Cells. | Front Physiol | 2022 | 35330932 | PubTator, text mining | PubMed |
| Inferring Time-Lagged Causality Using the Derivative of Single-Cell Expression. | Int J Mol Sci | 2022 | 35328768 | PubTator, text mining | PubMed |
| The Role of LSD1 and LSD2 in Cancers of the Gastrointestinal System: An Update. | Biomolecules | 2022 | 35327654 | PubTator, text mining | PubMed |
| MicroRNA Roles in Cell Reprogramming Mechanisms. | Cells | 2022 | 35326391 | PubTator, text mining | PubMed |
| Successful Treatment of a Patient With Multiple-Line Relapsed Extensive-Stage Small-Cell Lung Cancer Receiving Penpulimab Combined With Anlotinib: A Case Report. | Front Oncol | 2022 | 35321433 | PubTator, text mining | PubMed |
| The Specific Role of Reactive Astrocytes in Stroke. | Front Cell Neurosci | 2022 | 35321205 | PubTator, text mining | PubMed |
| Analysis of Genes Associated with Both Neural Tube Defects and Neuroectodermal Tumors. | Med Sci Monit | 2022 | 35318299 | PubTator, text mining | PubMed |
| Killing SCLC: insights into how to target a shapeshifting tumor. | Genes Dev | 2022 | 35318269 | PubTator, text mining | PubMed |
| Prognostic Implications of Molecular Subtypes in Primary Small Cell Lung Cancer and Their Correlation With Cancer Immunity. | Front Oncol | 2022 | 35311069 | PubTator, text mining | PubMed |
| Whole-Process Treatment of Combined Small Cell Lung Cancer Initially Diagnosed as "Lung Squamous Cell Carcinoma": A Case Report and Review of the Literature. | Front Immunol | 2022 | 35309345 | PubTator, text mining | PubMed |
| A clinician's handbook for using ctDNA throughout the patient journey. | Mol Cancer | 2022 | 35307037 | PubTator, text mining | PubMed |
| Identification of hub genes and transcription factors in patients with rheumatoid arthritis complicated with atherosclerosis. | Sci Rep | 2022 | 35304503 | PubTator, text mining | PubMed |
| Bioorthogonal Chemical Epigenetic Modifiers Enable Dose-Dependent CRISPR Targeted Gene Activation in Mammalian Cells. | ACS Synth Biol | 2022 | 35302756 | PubTator, text mining | PubMed |
| A defined human-specific platform for modeling neuronal network stimulation in vitro and in silico. | J Neurosci Methods | 2022 | 35292305 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/429/papers?page=66